Fenfluramine HCl not checked
UCB BIOSCIENCES, Inc. · ZX0008 · ZX008
FollowEvery change as it happens, and a Monday email
Trials
2 active
4 in total · 3 in the EU
What this is
- How it works
- How it works isn't classified yet
- Tested for
- Rett Syndrome
- Main trialPhase 3
- “The purpose of this study is to investigate the efficacy of fenfluramine hydrochloride (HCl) versus placebo in study participants with Rett syndrome (RTT).”In the company’s words, NCT07503444 on ClinicalTrials.gov
- Other names
- Fintepla · ZX0008 · fenfluramine · fenfluramine hydrochloride · ZX008
Other drugs for Rett Syndrome
- BionetideBiomed Industries · Phase 3
- NTI164Fenix Innovation Group · Phase 2/3
- ION440Ionis Pharmaceuticals, Inc. · Phase 1/2
- VorinostatUnravel Biosciences, Inc. · Phase 1
Coming up1
- 6 Feb 2029Phase 3 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials4
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Recruiting | 6 Feb 2029 | A Phase 3 Study of Fenfluramine Hydrochloride in Rett Syndrome | |
| Phase 3Completed | 1 Sep 2026 | A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Fenfluramine (Hydrochloride) in Infants 1 Year to Less Than 2 Years of Age With Dravet Syndrome | |
| Phase 1Completed | 12 Jun 2025 | A Study to Assess Drug-drug Interaction of ZX008 in Healthy Male and Female Study Participants | |
| Phase 2Authorised | not given | Open label extension study for monitoring long-term safety in patients with Myoclonic Astatic Epilepsy (Doose-Syndrome) receiving Fenfluramine as add-on therapy |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026